Evidence map›Paper›PMID 35167968›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2022

A challenging response to a Lassa fever outbreak in a non endemic area of Sierra Leone in 2019 with export of cases to The Netherlands.

Charles Njuguna, Mohamed Vandi, Evans Liyosi, Jane Githuku, Alie Wurie, Ian Njeru, Philomena Raftery, Claudette Amuzu, Anna Maruta, Robert Musoke and 5 more

Open access · goldAbstract read
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Nosocomial Outbreak of Lassa Fever in Conakry, Guinea, 2022.The Journal of infectious diseases · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Lassa Fever: Critical Review and Prospects for Control.Tropical medicine and infectious disease · 2024
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 3 countries.

Charles NjugunaWorld Health Organization Country office, Sierra Leone. Electronic address: njugunach@who.int.
Mohamed VandiSierra Leone Ministry of Health and Sanitation.
Evans LiyosiWorld Health Organization Country office, Sierra Leone.
Jane GithukuWorld Health Organization Country office, Sierra Leone.
Alie WurieSierra Leone Ministry of Health and Sanitation.
Ian NjeruWorld Health Organization Country office, Sierra Leone.
Philomena RafteryWorld Health Organization Country office, Sierra Leone.
Claudette AmuzuWorld Health Organization Country office, Sierra Leone.
Anna MarutaWorld Health Organization Country office, Sierra Leone.
Robert MusokeWorld Health Organization Country office, Sierra Leone.
Mukeh FahnbullehSierra Leone Ministry of Health and Sanitation.
Joseph BuntingSierra Leone Ministry of Health and Sanitation.
Simeon GbandehSierra Leone Ministry of Health and Sanitation.
Ambrose TalisunaWorld Health Organization Regional Office for Africa, Brazzaville.
Zabulon YotiWorld Health Organization Regional Office for Africa, Brazzaville.
University of Sierra Leone · SLWorld Health Organization Regional Office for Africa · CGWorld Health Organization - Pakistan · PK

Funding

World Health Organization 001
6 · The paper itself

Abstract

introductionOn November 20, 2019, the Sierra Leone International Health Regulations (IHR) National Focal Point was notified of an exported case of Lassa fever in The Netherlands, by a Dutch doctor who previously practiced in a rural hospital in Sierra Leone. This report describes the extent of the outbreak, possible sources of infection, and the outbreak response measures taken.

methodsResponse measures implemented to control the outbreak included coordination across multiple countries and cities, outbreak investigation, active case finding, contact tracing and monitoring, laboratory investigation, and isolation and treatment of cases.

resultsWe report a hospital-associated outbreak that resulted in 3 confirmed cases (health workers) and 2 probable cases (patients). The case fatality rate was 60%, whereas the secondary attack rate was 14%. Two cases involved exportations to The Netherlands. Failure to detect the index case and poor adherence to infection prevention and control (IPC) protocols contributed to disease spread. Pregnancy status and nonspecific signs and symptoms of the index case contributed to failure in early case detection.

conclusionsRapid activation of national and subnational incident management systems resulted in rapid outbreak control. We recommend regular training for clinicians on surveillance and IPC protocols and strengthening in-country Lassa virus diagnostic capacity.

Indexed as

Hemorrhagic Fever, EbolaLassa FeverDisease OutbreaksFemaleHumansLassa virusNetherlandsPregnancySierra LeoneHospital-Associated InfectionLassa FeverOutbreakSierra Leone

Identifiers

PMID35167968
PMCPMC8948091
OpenAlexW4211124154

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.